RESMED INC — Director's Dealing 2015

Nov 4, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2015-11-02

Reporting Person: Douglas Robert Andrew (President and COO ResMed Inc.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-11-02	ResMed Common Stock	S	500	$57.65	Disposed	54338.764	Indirect
2015-11-02	ResMed Common Stock	M	5833	$19.25	Acquired	60171.764	Indirect
2015-11-02	ResMed Common Stock	S	5833	$57.599	Disposed	54338.764	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-11-02	ResMed Common Stock Options	$19.25	M	5833	Disposed	2016-02-03	ResMed Common Stock (5833)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
ResMed Common Stock	68390.5778	Direct

Footnotes

F1: The transaction was conducted under a 10b5-1 Plan as defined under the Securities Exchange Act of 1934, as amended.

F2: Represents date options first became exercisable.

F3: This transaction was executed in multiple trades at prices ranging from $57.53 to $57.65. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.

F4: Includes 211.5778 shares purchased on October 30, 2015, pursuant to the ResMed Employee Stock Purchase Plan.